The American Diabetes Association (ADA) has made its annual changes to its Standards of Medical Care in Diabetes. This year there is a strong recurring message of individualising patient care, ...
Almost 13,000 leading physicians, scientists and health care professionals from around the world convene each year at the American Diabetes Association’s Scientific Sessions to unveil ...
The American Diabetes Association (ADA) has included several new and revised clinical practice recommendations in its 2019 Standards of Medical Care in Diabetes. The ADA say the changes ...
The winner of a global type 2 diabetes innovation competition will be announced later this week. Six finalists were whittled down from 116 entries as part of the Ascensia Diabetes Challenge, ...
The American Diabetes Association (ADA) has published its annual care recommendations to reflect the latest advances in evidence-based research. Notable new recommendations in the 2018 edition ...
Greater investment in trials and improved consistency of safety reports are among new recommendations issued to help continuous glucose monitoring (CGM) technologies achieve full potential. The ...
A position statement based on hypertension and diabetes has been released in the US. The document, which was last updated in 2003, was written by nine leading diabetes experts on behalf of the ...
New ® (empagliflozin) data shows that reduced risk for cardiovascular (CV) was consistent across age groups in adults with type 2 diabetes. The findings, which were presented at the American ...
The GLP-1 receptor analogue Victoza® (liraglutide) significantly reduced the risk of major cardiovascular events and death in adults with type 2 diabetes in the LEADER trial, Novo Nordisk has ...
Adults with type 1 diabetes treated with faster-acting insulin aspart had significantly reduced HbA1c and improved postprandial glucose (PPG) control after two-hours when compared with NovoRapid® ...